TB-500 vs Thymosin Beta-4
A side-by-side research comparison of TB-500 and Thymosin Beta-4 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | TB-500 | Thymosin Beta-4 |
|---|---|---|
| Full name | Thymosin Beta-4 (Synthetic) | Thymosin Beta-4 (Full Length) |
| Category | Healing & Recovery | Healing & Recovery |
| Status | Research compound | Research compound |
| Mechanism | Upregulates actin production to promote cell migration and proliferation, enhances angiogenesis, and reduces pro-inflammatory cytokines. | Sequesters G-actin to regulate cytoskeleton dynamics, promotes stem cell differentiation, and activates anti-inflammatory and anti-apoptotic pathways. |
| Molecular weight | 4921 Da | 4921 Da |
| Half-life | ~6 hours | ~6-8 hours |
| Bioavailability | ~95% via subcutaneous injection | ~95% subcutaneous |
| Typical dose | 2-5 mg per dose | 1-5 mg |
| Frequency | Loading: 2x/week · Maintenance: 1x/week | 2-3x per week |
| Route | Subcutaneous injection | Subcutaneous injection |
TB-500 reported benefits
- Enhanced wound healing
- Reduced inflammation
- Improved flexibility
- Cardiac tissue repair
- Hair regrowth support
Thymosin Beta-4 reported benefits
- Comprehensive tissue repair
- Cardiac regeneration
- Neurological recovery
- Corneal healing
- Anti-fibrotic effects
Related comparisons
Research and educational reference only. Not medical advice.